Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 6/2018

01-11-2018 | Laboratory Investigation

Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells

Authors: Naoki Kusunose, Takahiro Akamine, Yoshiyuki Kobayashi, Shigeo Yoshida, Kenichi Kimoto, Sai Yasukochi, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo, Toshiaki Kubota

Published in: Japanese Journal of Ophthalmology | Issue 6/2018

Login to get access

Abstract

Purpose

Clock genes are components of the molecular clock. Their malfunction is thought to increase the risk of numerous diseases, including cancer. Vascular endothelial growth factor (VEGF) has a pivotal role in angiogenesis, and its expression levels are controlled by clock genes in tumor cells. Ophthalmic diseases such as age-related macular degeneration, proliferative diabetic retinopathy, and neovascular glaucoma are also associated with abnormal angiogenesis followed by upregulation of VEGF in the eye. In the present study, we aimed to uncover the relationship between clock genes and VEGF in the eye.

Study design

Laboratory investigation

Methods

Oxygen-induced retinopathy (OIR) mice were prepared to mimic hypoxic conditions in the eye. Deferoxamine (DFO) was used to mimic hypoxic conditions in human Müller cell line MIO-M1 cells. Expression levels of mRNA and protein were quantified by quantitative reverse transcription polymerase chain reaction and Western blot analysis, respectively.

Results

In the retinas of OIR mice, the expression levels of Vegf and the clock gene Dec2 increased transiently, and their temporal profiles were correlated. Knockdown of DEC2 resulted in a significant (26.7%) reduction of VEGF expression in MIO-M1 cells under hypoxia-mimicking conditions induced by DFO (P < .05). Levels of HIF1α protein were also reduced significantly, by 60.2%, in MIO-M1 cells treated with siRNA against the DEC2 gene (P < .05). Moreover, HIF1α levels showed a significant (2.5-fold) increase in MIO-M1 cells overexpressing DEC2 (P < .05).

Conclusion

DEC2 could upregulate retinal VEGF gene expression through modulation of HIF1α levels under hypoxic conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10:145–7.CrossRef Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10:145–7.CrossRef
2.
go back to reference Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2004;438:960–6.CrossRef Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2004;438:960–6.CrossRef
3.
go back to reference Osaadon P, Fagan X, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye. 2014;28:510–20.CrossRef Osaadon P, Fagan X, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye. 2014;28:510–20.CrossRef
4.
go back to reference SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Ophthalmol. 2013;28:165–72. SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Ophthalmol. 2013;28:165–72.
5.
go back to reference Kimoto K, Kubota T. Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol. 2012;2012:852183.PubMed Kimoto K, Kubota T. Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol. 2012;2012:852183.PubMed
6.
go back to reference Selvaraj K, Gowthamarajan K, Karri VVSR, Barauah UK, Ravisankar V, Jojo GM. Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy. J Drug Target. 2017;25:386–405.CrossRef Selvaraj K, Gowthamarajan K, Karri VVSR, Barauah UK, Ravisankar V, Jojo GM. Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy. J Drug Target. 2017;25:386–405.CrossRef
7.
go back to reference Hamet P, Tremblay J. Genetics of the sleep-wake cycle and its disorders. Metab Clin Exp. 2006;55:S7–12.CrossRef Hamet P, Tremblay J. Genetics of the sleep-wake cycle and its disorders. Metab Clin Exp. 2006;55:S7–12.CrossRef
8.
go back to reference Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet. 2007;22:3–14.CrossRef Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet. 2007;22:3–14.CrossRef
9.
go back to reference Koyanagi S, Kusunose N, Taniguchi M, Akamine T, Kanado Y, Ozono Y, et al. Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia. Nat Commun. 2016;7:13102.CrossRef Koyanagi S, Kusunose N, Taniguchi M, Akamine T, Kanado Y, Ozono Y, et al. Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia. Nat Commun. 2016;7:13102.CrossRef
10.
go back to reference Okamura H, Yamaguchi S, Yagita K. Molecular machinery of the circadian clock in mammals. Cell Tissue Res. 2002;309:47–56.CrossRef Okamura H, Yamaguchi S, Yagita K. Molecular machinery of the circadian clock in mammals. Cell Tissue Res. 2002;309:47–56.CrossRef
11.
go back to reference Ueda HR, Iino M, Machida M, Sano M, Hayashi S, Hashimoto S, et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet. 2005;37:187.CrossRef Ueda HR, Iino M, Machida M, Sano M, Hayashi S, Hashimoto S, et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet. 2005;37:187.CrossRef
12.
go back to reference Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev. 2003;4:649–61.CrossRef Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev. 2003;4:649–61.CrossRef
13.
go back to reference Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002;419:841–4.CrossRef Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002;419:841–4.CrossRef
14.
go back to reference He Y, Jones CR, Fujiki N, Xu Y, Guo B, Holder JL, et al. The transcriptional repressor DEC2 regulates sleep length in mammals. Science. 2009;325:866–70.CrossRef He Y, Jones CR, Fujiki N, Xu Y, Guo B, Holder JL, et al. The transcriptional repressor DEC2 regulates sleep length in mammals. Science. 2009;325:866–70.CrossRef
15.
go back to reference Sato F, Bhawal UK, Yoshimura T, Muragaki Y. DEC1 and DEC2 crosstalk between circadian rhythm and tumor progression. J Cancer. 2016;7:153–9.CrossRef Sato F, Bhawal UK, Yoshimura T, Muragaki Y. DEC1 and DEC2 crosstalk between circadian rhythm and tumor progression. J Cancer. 2016;7:153–9.CrossRef
16.
go back to reference Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, et al. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells. 2008;13:131–44.CrossRef Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, et al. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells. 2008;13:131–44.CrossRef
17.
go back to reference Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003;63:7277–83.PubMed Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003;63:7277–83.PubMed
18.
go back to reference Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Abe T, Kiyonari H, et al. Different roles played by periostin splice variants in retinal neovascularization. Exp Eye Res. 2016;153:133–40.CrossRef Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Abe T, Kiyonari H, et al. Different roles played by periostin splice variants in retinal neovascularization. Exp Eye Res. 2016;153:133–40.CrossRef
19.
go back to reference Ren H, Thiersch M, Grimm C. Mimicking hypoxia by the chemical stabilization of Hif-1α in the mouse retina. Invest Ophthalmol Vis Sci. 2007;48:625. Ren H, Thiersch M, Grimm C. Mimicking hypoxia by the chemical stabilization of Hif-1α in the mouse retina. Invest Ophthalmol Vis Sci. 2007;48:625.
20.
go back to reference Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res. 2001;49:614–7.CrossRef Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res. 2001;49:614–7.CrossRef
21.
go back to reference Nürnberg C, Kociok N, Brockmann C, Lischke T, Crespo-Garcia S, Reichhart N, et al. Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells. Exp Eye Res. 2018;166:56–69.CrossRef Nürnberg C, Kociok N, Brockmann C, Lischke T, Crespo-Garcia S, Reichhart N, et al. Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells. Exp Eye Res. 2018;166:56–69.CrossRef
22.
go back to reference Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol. 2006;37:1–12.CrossRef Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol. 2006;37:1–12.CrossRef
23.
go back to reference Chen S, Sang N. Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors. J Biomed Biotechnol. 2011;2011:197946.PubMed Chen S, Sang N. Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors. J Biomed Biotechnol. 2011;2011:197946.PubMed
24.
go back to reference Joshi S, Singh AR, Durden DL. MDM2 regulates hypoxic hypoxia-inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem. 2014;289:22785–97.CrossRef Joshi S, Singh AR, Durden DL. MDM2 regulates hypoxic hypoxia-inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem. 2014;289:22785–97.CrossRef
25.
go back to reference Kim EJ, Yoo YG, Yang WK, Lim YS, Na TY, Lee IK, et al. Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling. Arterioscler Thromb Vasc Biol. 2008;28:1796–802.CrossRef Kim EJ, Yoo YG, Yang WK, Lim YS, Na TY, Lee IK, et al. Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling. Arterioscler Thromb Vasc Biol. 2008;28:1796–802.CrossRef
26.
go back to reference Akashi M, Okamoto A, Tsuchiya Y, Todo T, Nishida E, Node K. A positive role for PERIOD in mammalian circadian gene expression. Cell Rep. 2014;7:1056–64.CrossRef Akashi M, Okamoto A, Tsuchiya Y, Todo T, Nishida E, Node K. A positive role for PERIOD in mammalian circadian gene expression. Cell Rep. 2014;7:1056–64.CrossRef
27.
go back to reference Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med. 2012;18:774–82.CrossRef Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med. 2012;18:774–82.CrossRef
28.
go back to reference Kobayashi M, Morinibu A, Koyasu S, Goto Y, Hiraoka M, Harada H. A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes. FEBS J. 2017;284:3804–16.CrossRef Kobayashi M, Morinibu A, Koyasu S, Goto Y, Hiraoka M, Harada H. A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes. FEBS J. 2017;284:3804–16.CrossRef
29.
go back to reference Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012;487:380–4.CrossRef Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012;487:380–4.CrossRef
30.
go back to reference Hu T, He N, Yang Y, Yin C, Sang N, Yang Q. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. J Exp Clin Cancer Res. 2015;34:22.CrossRef Hu T, He N, Yang Y, Yin C, Sang N, Yang Q. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. J Exp Clin Cancer Res. 2015;34:22.CrossRef
31.
go back to reference Wu Y, Sato H, Suzuki T, Yoshizawa T, Morohashi S, Seino H, et al. Involvement of c-myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2. Int J Mol Med. 2015;35:815–20.CrossRef Wu Y, Sato H, Suzuki T, Yoshizawa T, Morohashi S, Seino H, et al. Involvement of c-myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2. Int J Mol Med. 2015;35:815–20.CrossRef
32.
go back to reference Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51:2813–26.CrossRef Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51:2813–26.CrossRef
33.
go back to reference Olkkonen J, Kouri V, Hynninen J, Konttinen YT, Mandelin J. Differentially expressed in chondrocytes 2 (DEC2) increases the expression of IL-1β and is abundantly present in synovial membrane in rheumatoid arthritis. PloS One. 2015;10:e0145279.CrossRef Olkkonen J, Kouri V, Hynninen J, Konttinen YT, Mandelin J. Differentially expressed in chondrocytes 2 (DEC2) increases the expression of IL-1β and is abundantly present in synovial membrane in rheumatoid arthritis. PloS One. 2015;10:e0145279.CrossRef
34.
go back to reference Kaštelan S, Tomić M, Gverović Antunica A, Salopek Rabatić J, Ljubić S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013;2013:213130.PubMedPubMedCentral Kaštelan S, Tomić M, Gverović Antunica A, Salopek Rabatić J, Ljubić S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013;2013:213130.PubMedPubMedCentral
35.
go back to reference Juel HB, Faber C, Udsen MS, Folkersen L, Nissen MH. Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T Cells. Invest Ophthalmol Vis Sci. 2012;53:8472–80.CrossRef Juel HB, Faber C, Udsen MS, Folkersen L, Nissen MH. Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T Cells. Invest Ophthalmol Vis Sci. 2012;53:8472–80.CrossRef
36.
go back to reference Mahoney MM. Shift work, jet lag, and female reproduction. Int J Endocrinol. 2010;2010:813764.CrossRef Mahoney MM. Shift work, jet lag, and female reproduction. Int J Endocrinol. 2010;2010:813764.CrossRef
37.
go back to reference Haus E, Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control. 2006;17:489–500.CrossRef Haus E, Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control. 2006;17:489–500.CrossRef
38.
go back to reference Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev. 1995;19:553–71.CrossRef Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev. 1995;19:553–71.CrossRef
39.
go back to reference Kusunose N, Matsunaga N, Kimoto K, Akamine T, Hamamura K, Koyanagi S, et al. Mitomycin C modulates the circadian oscillation of clock gene period 2 expression through attenuating the glucocorticoid signaling in mouse fibroblasts. Biochem Biophys Res Commun. 2015;467:157–63.CrossRef Kusunose N, Matsunaga N, Kimoto K, Akamine T, Hamamura K, Koyanagi S, et al. Mitomycin C modulates the circadian oscillation of clock gene period 2 expression through attenuating the glucocorticoid signaling in mouse fibroblasts. Biochem Biophys Res Commun. 2015;467:157–63.CrossRef
40.
go back to reference Lim F, Currie R, Orphanides G, Moggs J. Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review. Xenobiotica. 2006;36:1140–51.CrossRef Lim F, Currie R, Orphanides G, Moggs J. Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review. Xenobiotica. 2006;36:1140–51.CrossRef
41.
go back to reference Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291:1040–3.CrossRef Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291:1040–3.CrossRef
42.
go back to reference Takeda N, Maemura K. The role of clock genes and circadian rhythm in the development of cardiovascular diseases. Cell Mol Life Sci. 2015;72:3225–34.CrossRef Takeda N, Maemura K. The role of clock genes and circadian rhythm in the development of cardiovascular diseases. Cell Mol Life Sci. 2015;72:3225–34.CrossRef
43.
go back to reference Takahashi JS, Hong H, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008;9:764–75.CrossRef Takahashi JS, Hong H, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008;9:764–75.CrossRef
44.
go back to reference Wang Q, Tikhonenko M, Bozack SN, Lydic TA, Yan L, Panchy NL, et al. Changes in the daily rhythm of lipid metabolism in the diabetic retina. PLoS One. 2014;9:e95028.CrossRef Wang Q, Tikhonenko M, Bozack SN, Lydic TA, Yan L, Panchy NL, et al. Changes in the daily rhythm of lipid metabolism in the diabetic retina. PLoS One. 2014;9:e95028.CrossRef
45.
go back to reference Wang Q, Bozack SN, Yan Y, Boulton ME, Grant MB, Busik JV. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina. Invest Ophthalmol Vis Sci. 2014;55:3986–94.CrossRef Wang Q, Bozack SN, Yan Y, Boulton ME, Grant MB, Busik JV. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina. Invest Ophthalmol Vis Sci. 2014;55:3986–94.CrossRef
Metadata
Title
Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells
Authors
Naoki Kusunose
Takahiro Akamine
Yoshiyuki Kobayashi
Shigeo Yoshida
Kenichi Kimoto
Sai Yasukochi
Naoya Matsunaga
Satoru Koyanagi
Shigehiro Ohdo
Toshiaki Kubota
Publication date
01-11-2018
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 6/2018
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-018-0622-5

Other articles of this Issue 6/2018

Japanese Journal of Ophthalmology 6/2018 Go to the issue